A mechanistic evolutionary model explains the time-dependent pattern of substitution rates in viruses.

coronavirus foamy virus hepatitis C virus molecular clock mutation rate paleovirology site saturation substitution rate substitution saturation time-dependent rate phenomenon

Journal

Current biology : CB
ISSN: 1879-0445
Titre abrégé: Curr Biol
Pays: England
ID NLM: 9107782

Informations de publication

Date de publication:
08 11 2021
Historique:
received: 12 03 2021
revised: 02 06 2021
accepted: 05 08 2021
pubmed: 4 9 2021
medline: 25 11 2021
entrez: 3 9 2021
Statut: ppublish

Résumé

Estimating viral timescales is fundamental in understanding the evolutionary biology of viruses. Molecular clocks are widely used to reveal the recent evolutionary histories of viruses but may severely underestimate their longer-term origins because of the inverse correlation between inferred rates of evolution and the timescale of their measurement. Here, we provide a predictive mechanistic model that readily explains the rate decay phenomenon over a wide range of timescales and recapitulates the ubiquitous power-law rate decay with a slope of -0.65. We show that standard substitution models fail to correctly estimate divergence times once the most rapidly evolving sites saturate, typically after hundreds of years in RNA viruses and thousands of years in DNA viruses. Our model successfully recreates the observed pattern of decay and explains the evolutionary processes behind the time-dependent rate phenomenon. We then apply our model to re-estimate the date of diversification of genotypes of hepatitis C virus to 423,000 (95% highest posterior density [HPD]: 394,000-454,000) years before present, a time preceding the dispersal of modern humans out of Africa, and show that the most recent common ancestor of sarbecoviruses dates back to 21,000 (95% HPD: 19,000-22,000) years ago, nearly thirty times older than previous estimates. This creates a new perspective for our understanding of the origins of these viruses and also suggests that a substantial revision of evolutionary timescales of other viruses can be similarly achieved.

Identifiants

pubmed: 34478645
pii: S0960-9822(21)01124-6
doi: 10.1016/j.cub.2021.08.020
pmc: PMC8585505
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4689-4696.e5

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M011224/1
Pays : United Kingdom

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Mol Biol Evol. 1984 Apr;1(3):269-85
pubmed: 6599968
PLoS Pathog. 2014 Nov 06;10(11):e1004475
pubmed: 25375184
Nat Rev Genet. 2007 Mar;8(3):196-205
pubmed: 17262054
J Viral Hepat. 1997;4 Suppl 1:69-74
pubmed: 9097281
Philos Trans R Soc Lond B Biol Sci. 2013 Feb 04;368(1614):20120382
pubmed: 23382435
Nature. 2018 May;557(7705):418-423
pubmed: 29743673
EMBO J. 2005 Apr 20;24(8):1634-43
pubmed: 15791205
Mol Biol Evol. 2019 Aug 1;36(8):1793-1803
pubmed: 31004175
Clin Microbiol Rev. 2001 Jan;14(1):165-76
pubmed: 11148008
PLoS Biol. 2004 Sep;2(9):E275
pubmed: 15269786
Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6261-5
pubmed: 17384150
J Virol. 2016 Jul 27;90(16):7184-95
pubmed: 27252529
Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20362-7
pubmed: 19075221
Nat Commun. 2017 Jan 10;8:13954
pubmed: 28071651
Curr Opin Virol. 2016 Feb;16:1-7
pubmed: 26517843
Science. 2019 Mar 22;363(6433):1319-1326
pubmed: 30765607
Mol Biol Evol. 2005 Jul;22(7):1561-8
pubmed: 15814826
J Mol Evol. 1981;17(6):368-76
pubmed: 7288891
Nature. 2005 Mar 17;434(7031):376-80
pubmed: 15772660
Virology. 2014 Sep;464-465:233-243
pubmed: 25105489
Curr Biol. 2016 Dec 19;26(24):3407-3412
pubmed: 27939314
Mol Biol Evol. 2011 Dec;28(12):3355-65
pubmed: 21705379
Science. 2009 Sep 18;325(5947):1512
pubmed: 19762636
Nat Rev Genet. 2008 Apr;9(4):267-76
pubmed: 18319742
Mol Biol Evol. 2007 Aug;24(8):1853-60
pubmed: 17545188
Biochem Soc Trans. 2000 Feb;28(2):275-82
pubmed: 10816142
J Gen Virol. 2009 Sep;90(Pt 9):2086-96
pubmed: 19474244
Proc Biol Sci. 2014 Jul 7;281(1786):
pubmed: 24850916
Curr Opin Virol. 2011 Nov;1(5):436-41
pubmed: 22440848
Science. 2020 Jun 19;368(6497):1367-1370
pubmed: 32554594
J Virol. 1999 Nov;73(11):9256-65
pubmed: 10516034
Nat Microbiol. 2020 Nov;5(11):1408-1417
pubmed: 32724171
Nat Rev Microbiol. 2019 May;17(5):321-328
pubmed: 30518814
BMC Evol Biol. 2015 Jun 26;15:119
pubmed: 26111824
Curr Top Microbiol Immunol. 2006;299:371-401
pubmed: 16568907
J Infect Dis. 2004 Sep 15;190(6):1098-108
pubmed: 15319860
PLoS Genet. 2010 Nov 18;6(11):e1001191
pubmed: 21124940
Mol Ecol. 2011 Aug;20(15):3087-101
pubmed: 21740474
Nat Rev Genet. 2009 Aug;10(8):540-50
pubmed: 19564871
Nature. 2013 Jun 20;498(7454):310-1
pubmed: 23783626
Proc Natl Acad Sci U S A. 2018 Jul 17;115(29):7557-7562
pubmed: 29967156
Curr Biol. 2021 Aug 23;31(16):3504-3514.e9
pubmed: 34171302

Auteurs

Mahan Ghafari (M)

Department of Zoology, University of Oxford, Oxford, UK.

Peter Simmonds (P)

Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Oliver G Pybus (OG)

Department of Zoology, University of Oxford, Oxford, UK.

Aris Katzourakis (A)

Department of Zoology, University of Oxford, Oxford, UK. Electronic address: aris.katzourakis@zoo.ox.ac.uk.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH